Yang C - Search Results

1

Cancer-Associated Fibroblast-Mediated Cellular Crosstalk Supports Hepatocellular Carcinoma Progression.

Song M, He J, Pan QZ, Yang J, Zhao J, Zhang YJ, Huang Y, Tang Y, Wang Q, He J, Gu J, Li Y, Chen S, Zeng J, Zhou ZQ, Yang C, Han Y, Chen H, Xiang T, Weng DS, Xia JC. Song M, et al. Among authors: yang c, yang j. Hepatology. 2021 May;73(5):1717-1735. doi: 10.1002/hep.31792. Hepatology. 2021. PMID: 33682185

2

Large-scale analyses identify a cluster of novel long noncoding RNAs as potential competitive endogenous RNAs in progression of hepatocellular carcinoma.

Song M, Zhong A, Yang J, He J, Cheng S, Zeng J, Huang Y, Pan Q, Zhao J, Zhou Z, Zhu Q, Tang Y, Chen H, Yang C, Liu Y, Mo X, Weng D, Xia JC. Song M, et al. Among authors: yang c, yang j. Aging (Albany NY). 2019 Nov 23;11(22):10422-10453. doi: 10.18632/aging.102468. Epub 2019 Nov 23. Aging (Albany NY). 2019. PMID: 31761783 Free PMC article.

3

Acylglycerol kinase promotes tumour growth and metastasis via activating the PI3K/AKT/GSK3β signalling pathway in renal cell carcinoma.

Zhu Q, Zhong AL, Hu H, Zhao JJ, Weng DS, Tang Y, Pan QZ, Zhou ZQ, Song MJ, Yang JY, He JY, Liu Y, Li M, Hu WM, Yang CP, Xiang T, Chen MY, Ma G, Guo L, Xia JC. Zhu Q, et al. J Hematol Oncol. 2020 Jan 3;13(1):2. doi: 10.1186/s13045-019-0840-4. J Hematol Oncol. 2020. PMID: 31900208 Free PMC article.

4

Efficacy of adjuvant cytokine-induced killer cell immunotherapy in patients with colorectal cancer after radical resection.

Pan QZ, Zhao JJ, Yang CP, Zhou YQ, Lin JZ, Tang Y, Gu JM, Wang QJ, Li YQ, He J, Chen SP, Song MJ, Huang Y, Yang JY, Weng DS, Xia JC. Pan QZ, et al. Oncoimmunology. 2020 Apr 17;9(1):1752563. doi: 10.1080/2162402X.2020.1752563. eCollection 2020. Oncoimmunology. 2020. PMID: 32363125 Free PMC article.

5

Galectin-3 favours tumour metastasis via the activation of β-catenin signalling in hepatocellular carcinoma.

Song M, Pan Q, Yang J, He J, Zeng J, Cheng S, Huang Y, Zhou ZQ, Zhu Q, Yang C, Han Y, Tang Y, Chen H, Weng DS, Xia JC. Song M, et al. Among authors: yang c, yang j. Br J Cancer. 2020 Nov;123(10):1521-1534. doi: 10.1038/s41416-020-1022-4. Epub 2020 Aug 17. Br J Cancer. 2020. PMID: 32801345 Free PMC article.

6

Severe delayed pulmonary toxicity following PD-L1-specific CAR-T cell therapy for non-small cell lung cancer.

Liu H, Ma Y, Yang C, Xia S, Pan Q, Zhao H, Fang W, Chen X, Zhang Y, Zou B, Li Q, Wan Y, Chen H, Tang Y, Zhao J, Weng D, Xia L, Zhang L, Xia J. Liu H, et al. Among authors: yang c. Clin Transl Immunology. 2020 Oct 9;9(10):e1154. doi: 10.1002/cti2.1154. eCollection 2020. Clin Transl Immunology. 2020. PMID: 33072320 Free PMC article.

7

The efficacy and safety of the combination of axitinib and pembrolizumab-activated autologous DC-CIK cell immunotherapy for patients with advanced renal cell carcinoma: a phase 2 study.

Song MJ, Pan QZ, Ding Y, Zeng J, Dong P, Zhao JJ, Tang Y, Li J, Zhang Z, He J, Yang J, Huang Y, Peng R, Wang QJ, Gu JM, He J, Li YQ, Chen SP, Huang R, Zhou ZQ, Yang C, Han Y, Chen H, Liu H, Xia S, Wan Y, Weng DS, Xia L, Zhou FJ, Xia JC. Song MJ, et al. Among authors: yang c, yang j. Clin Transl Immunology. 2021 Mar 3;10(3):e1257. doi: 10.1002/cti2.1257. eCollection 2021. Clin Transl Immunology. 2021. PMID: 33717483 Free PMC article.

8

Inhibition of DTYMK significantly restrains the growth of HCC and increases sensitivity to oxaliplatin.

Sun F, Liu Y, Gong T, Pan Q, Xiang T, Zhao J, Tang Y, Chen H, Han Y, Song M, Huang Y, Li H, Chen Y, Yang C, Yang J, Wang Q, Li Y, He J, Weng D, Peng R, Xia J. Sun F, et al. Among authors: yang c, yang j. Cell Death Dis. 2021 Nov 18;12(12):1093. doi: 10.1038/s41419-021-04375-3. Cell Death Dis. 2021. PMID: 34795209 Free PMC article.

9

EBV Infection in Epithelial Malignancies Induces Resistance to Antitumor Natural Killer Cells via F3-Mediated Platelet Aggregation.

Duan X, Chen H, Zhou X, Liu P, Zhang X, Zhu Q, Zhong L, Zhang W, Zhang S, Zhang X, Chen Y, Zhou Y, Yang C, Feng Q, Zeng YX, Xu M, Xiang T. Duan X, et al. Among authors: yang c. Cancer Res. 2022 Mar 15;82(6):1070-1083. doi: 10.1158/0008-5472.CAN-21-2292. Cancer Res. 2022. PMID: 35064016

10

CircITGB6 promotes ovarian cancer cisplatin resistance by resetting tumor-associated macrophage polarization toward the M2 phenotype.

Li H, Luo F, Jiang X, Zhang W, Xiang T, Pan Q, Cai L, Zhao J, Weng D, Li Y, Dai Y, Sun F, Yang C, Huang Y, Yang J, Tang Y, Han Y, He M, Zhang Y, Song L, Xia JC. Li H, et al. Among authors: yang c, yang j. J Immunother Cancer. 2022 Mar;10(3):e004029. doi: 10.1136/jitc-2021-004029. J Immunother Cancer. 2022. PMID: 35277458 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

44,953 results

Search Page